These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6352562)

  • 21. The effect of a factor from multiple sclerosis serum on isolated T and B lymphocytes.
    Armentrout SA; Sweet PM; Galant SP
    J Clin Lab Immunol; 1981 May; 5(3):133-6. PubMed ID: 6972451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular immune response to measles, mumps, and vaccinia viruses in multiple sclerosis.
    McFarland HF; McFarlin DE
    Ann Neurol; 1979 Aug; 6(2):101-6. PubMed ID: 315204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-typing and lymphocyte population studies in patients with multiple sclerosis.
    Reekers P; Hommes OR; Creemers-Molenaar J; Wijnings J; Kunst VA; Van Rood JJ
    J Neurol Sci; 1977 Aug; 33(1-2):143-53. PubMed ID: 71339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prospects and progress in the studies of neuroimmunology].
    Igata A
    Nihon Rinsho; 1983; 41(4):784-8. PubMed ID: 6350648
    [No Abstract]   [Full Text] [Related]  

  • 25. New concepts in the immunopathogenesis of multiple sclerosis.
    Hemmer B; Archelos JJ; Hartung HP
    Nat Rev Neurosci; 2002 Apr; 3(4):291-301. PubMed ID: 11967559
    [No Abstract]   [Full Text] [Related]  

  • 26. Multiple sclerosis: circulating antigen-reactive lymphocytes.
    Traugott U; Scheinberg LC; Raine CS
    Ann Neurol; 1979 Nov; 6(5):425-9. PubMed ID: 92911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular immunity in multiple sclerosis.
    Knight SC
    Br Med Bull; 1977 Jan; 33(1):45-50. PubMed ID: 137763
    [No Abstract]   [Full Text] [Related]  

  • 28. Lymphocyte subpopulations in the blood and cerebrospinal fluid of multiple sclerosis patients in active disease.
    Rukavina D; Sepcić J; Dorić M; Ledić P; Zaputović L; Eberhardt P
    Acta Neurol Scand; 1984 Mar; 69(3):182-5. PubMed ID: 6609518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T and B lymphocytes in multiple sclerosis.
    Lisak RP; Levinson AI; Zweiman B; Abdou NI
    Clin Exp Immunol; 1975 Oct; 22(1):30-4. PubMed ID: 1082395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating immune cells in multiple sclerosis.
    Jones AP; Kermode AG; Lucas RM; Carroll WM; Nolan D; Hart PH
    Clin Exp Immunol; 2017 Feb; 187(2):193-203. PubMed ID: 27689339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte function and the role of regulator cells in multiple sclerosis.
    Antel JP; Richman DP; Medof ME; Arnason BG
    Neurology; 1978 Sep; 28(9 Pt 2):106-10. PubMed ID: 309564
    [No Abstract]   [Full Text] [Related]  

  • 32. Reassessing B cell contributions in multiple sclerosis.
    Li R; Patterson KR; Bar-Or A
    Nat Immunol; 2018 Jul; 19(7):696-707. PubMed ID: 29925992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of hemosorption in disseminated sclerosis].
    Golovkin VI; Pershin VN; Tulenko AG
    Vrach Delo; 1986 Feb; (2):84-6. PubMed ID: 3486528
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuroimmunology I: Immunoregulation in neurological disease.
    Weiner HL; Hauser SL
    Ann Neurol; 1982 May; 11(5):437-49. PubMed ID: 6179458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation between progression of multiple sclerosis and immunogenetic as well as immunological factors].
    Cendrowski W
    Neurol Neurochir Pol; 1978; 12(2):157-60. PubMed ID: 79154
    [No Abstract]   [Full Text] [Related]  

  • 36. Proceedings: Immunogenetic aspects of demyelinating disease.
    Arnason BG; Chelmicka-Szorc E
    Neurology; 1975 May; 25(5):489. PubMed ID: 1079582
    [No Abstract]   [Full Text] [Related]  

  • 37. [Changes in the immunological reactivity of patients with disseminated sclerosis treated by prednisolone and the preparation Proper-Myl].
    Iarosh AA; Macheret EL; Iarosh AA; Zapadniuk BV
    Vrach Delo; 1990 Feb; (2):83-6. PubMed ID: 2339565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective immunoregulation in multiple sclerosis.
    Goust JM; Pryjma J; Hoffman PM; Hogan EL; Fudenberg HH
    Trans Am Neurol Assoc; 1979; 104():79-80. PubMed ID: 317937
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of antigen-specific T cells in multiple sclerosis twins with elevated responses to measles virus.
    Greenstein JI; Jacobson S; Richert JR; McFarland HF
    Ann N Y Acad Sci; 1984; 436():511-2. PubMed ID: 6085229
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunology of multiple sclerosis. Recent data and therapeutic perspectives].
    Tourbah A; Fontaine B; Lyon-Caen O
    Rev Neurol (Paris); 1993; 149(6-7):373-84. PubMed ID: 8303156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.